In analyses of non-AD pathology, VEGFB was positively associated with atherosclerosis (β = 0.006, SE = 0.003, and p = 0.039) and arteriolosclerosis (β = 0.008, SE = 0.003, and p = 0.013; see Supplementary Table 10). This evidence concerns the gene VEGFB and Alzheimer disease.